Lechu Yu

963 total citations
18 papers, 770 citations indexed

About

Lechu Yu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lechu Yu has authored 18 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lechu Yu's work include Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (6 papers) and Thyroid Disorders and Treatments (5 papers). Lechu Yu is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (6 papers) and Thyroid Disorders and Treatments (5 papers). Lechu Yu collaborates with scholars based in China and United States. Lechu Yu's co-authors include Xuemian Lu, Chi Zhang, Hong Yang, Xiufei Lin, Cheng Peng, Liangmiao Chen, Yi Tan, Xiaoqing Yan, Xiaokun Li and Lu Cai and has published in prestigious journals such as PLoS ONE, Life Sciences and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Lechu Yu

18 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lechu Yu China 15 388 187 98 97 93 18 770
Sumra Nazir Germany 9 330 0.9× 63 0.3× 117 1.2× 114 1.2× 85 0.9× 12 715
Hisashi Yokomizo Japan 12 266 0.7× 284 1.5× 41 0.4× 80 0.8× 78 0.8× 26 750
Alicja Czopek United Kingdom 15 307 0.8× 53 0.3× 53 0.5× 75 0.8× 75 0.8× 31 734
M. T. Chau China 11 188 0.5× 243 1.3× 89 0.9× 138 1.4× 76 0.8× 20 652
Liru Qiu China 11 236 0.6× 229 1.2× 31 0.3× 79 0.8× 42 0.5× 32 712
Karoline von Websky Germany 16 164 0.4× 339 1.8× 51 0.5× 36 0.4× 149 1.6× 25 793
Shanqun Jiang China 16 143 0.4× 96 0.5× 53 0.5× 66 0.7× 96 1.0× 54 688
Zhihong Zhang China 13 159 0.4× 79 0.4× 36 0.4× 105 1.1× 55 0.6× 28 596
Kirk Siddals United Kingdom 13 287 0.7× 312 1.7× 40 0.4× 60 0.6× 132 1.4× 31 616
Kengo Kidokoro Japan 18 318 0.8× 275 1.5× 22 0.2× 48 0.5× 67 0.7× 34 952

Countries citing papers authored by Lechu Yu

Since Specialization
Citations

This map shows the geographic impact of Lechu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lechu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lechu Yu more than expected).

Fields of papers citing papers by Lechu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lechu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lechu Yu. The network helps show where Lechu Yu may publish in the future.

Co-authorship network of co-authors of Lechu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lechu Yu. A scholar is included among the top collaborators of Lechu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lechu Yu. Lechu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Liangmiao, et al.. (2023). Association between third trimester maternal isolated hypothyroxinemia and adverse pregnancy outcomes. Endocrine Journal. 70(6). 611–618. 4 indexed citations
2.
Yu, Lechu, et al.. (2021). Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway. Journal of Diabetes Research. 2021. 1–14. 12 indexed citations
3.
Yu, Lechu, et al.. (2021). Astaxanthin attenuates alcoholic cardiomyopathy via inhibition of endoplasmic reticulum stress-mediated cardiac apoptosis. Toxicology and Applied Pharmacology. 412. 115378–115378. 33 indexed citations
4.
Xia, Fan, Meng Xue, Shiyue Sun, et al.. (2021). FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD+‐dependent manner. Journal of Cellular and Molecular Medicine. 25(6). 3091–3102. 22 indexed citations
5.
Chen, Liangmiao, et al.. (2020). Insignificant Effect of Isolated Hypothyroxinemia on Pregnancy Outcomes During the First and Second Trimester of Pregnancy. Frontiers in Endocrinology. 11. 528146–528146. 14 indexed citations
6.
Wang, Yi, Lulu He, Wanning Wang, et al.. (2020). Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice. Diabetes & Metabolism Journal. 44(4). 566–566. 15 indexed citations
7.
8.
Yang, Hong, Lechu Yu, Xiufei Lin, et al.. (2018). Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Cell Death and Disease. 9(2). 227–227. 103 indexed citations
9.
Zhang, Fangfang, Xiufei Lin, Lechu Yu, et al.. (2016). Low‐dose radiation prevents type 1 diabetes‐induced cardiomyopathy via activation of AKT mediated anti‐apoptotic and anti‐oxidant effects. Journal of Cellular and Molecular Medicine. 20(7). 1352–1366. 32 indexed citations
10.
Peng, Cheng, Fangfang Zhang, Lechu Yu, et al.. (2016). Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases. Journal of Diabetes Research. 2016. 1–8. 47 indexed citations
11.
Zhang, Chi, Fan Wang, Yimin Kang, et al.. (2015). Celecoxib prevents pressure overload‐induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. Journal of Cellular and Molecular Medicine. 20(1). 116–127. 53 indexed citations
12.
Zhang, Fangfang, Lechu Yu, Xiufei Lin, et al.. (2015). Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases. Molecular Endocrinology. 29(10). 1400–1413. 103 indexed citations
13.
Shao, Minglong, Lechu Yu, Fangfang Zhang, et al.. (2015). Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. American Journal of Physiology-Endocrinology and Metabolism. 309(1). E45–E54. 29 indexed citations
14.
Yang, Hong, Liangmiao Chen, Mengli Sun, et al.. (2014). Adiponectin and peroxisome proliferator-activated receptor-γ gene polymorphisms and gene-gene interactions with type 2 diabetes. Life Sciences. 98(1). 55–59. 7 indexed citations
15.
Yang, Hong, Minglong Shao, Liangmiao Chen, et al.. (2014). Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China. PLoS ONE. 9(6). e99611–e99611. 17 indexed citations
16.
Chen, Liangmiao, Jie Dai, Qian Zhang, et al.. (2014). Effects of Subclinical Hypothyroidism on Maternal and Perinatal Outcomes during Pregnancy: A Single-Center Cohort Study of a Chinese Population. PLoS ONE. 9(10). e109364–e109364. 114 indexed citations
17.
Chen, Liangmiao, Qian Zhang, Lechu Yu, et al.. (2014). Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women. Endocrine. 48(3). 924–928. 40 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumra Nazir Breakdown of academic impact, for papers by Hisashi Yokomizo Breakdown of academic impact, for papers by Alicja Czopek Breakdown of academic impact, for papers by M. T. Chau Breakdown of academic impact, for papers by Liru Qiu Breakdown of academic impact, for papers by Karoline von Websky Breakdown of academic impact, for papers by Shanqun Jiang Breakdown of academic impact, for papers by Zhihong Zhang Breakdown of academic impact, for papers by Kirk Siddals Breakdown of academic impact, for papers by Kengo Kidokoro
Rankless by CCL
2026